|
|
|
| home > ebr > winter 2003 > future of electronic data capture in clinical trials |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
| Clinical trials currently account for approximately 70 per cent of the US$403 million cost involved in bringing a new drug to market. This makes them an obvious target for those wanting to reduce drug discovery and development costs. The following scenario takes place in the future and suggests how technology may change the process. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Clinical Outsourcing World
7-8 February 2012, Earls Court Conference Centre – London
Clinical Outsourcing World enables you to make the right outsourcing decisions, streamline clinical practices, improve development times and efficiency and strengthen weak operational areas.
More info >> |
|
 |
News and Press Releases |
 |
More safety in drug packaging
In Germany like in the rest of the world, child safety in drug packaging is an issue that has not been properly solved yet. Today, Faubel, the custom label supplier based in Melsungen, provides a safe and economical solution consisting of an innovative safety label which can be affixed to the back of a tablet blister pack like an ordinary sticker.
More info >> |
|
|
